You just read:

Lenvatinib Phase II Results Published in The Lancet Oncology Show Significant Improvement in Progression-Free Survival When Used With Everolimus in Metastatic Renal Cell Carcinoma

News provided by

Eisai

16 Oct, 2015, 00:01 BST